News
Stem cell agency’s DEI program still a work in progress
The California Institute of Regenerative Medicine has strong requirements for Diversity, Equity and Inclusion. But there is clinker in the CIRM effort – secrecy.
The California Institute of Regenerative Medicine has strong requirements for Diversity, Equity and Inclusion. But there is clinker in the CIRM effort – secrecy.
Directors of the $12 billion California stem cell agency will face a fundamental question next week that could determine whether its efforts to produce revolutionary treatments for afflictions ranging from heart disease to cancer will live or die.
A crack opened last week for the first time in 17 years in the firewall between state politicians and the $12 billion California stem cell agency. It involves only $600,000 — at least for now — and is buried deep in the 1,069-page state budget bill that was introduced June 8. But its implications are far-reaching. They range from opening the agency to major changes — wanted and unwanted — to creating a basis for the agency’s currently dubious, long-term financial sustainability.